English Flag English العربية Flag العربية
 +(90) 5052646999   |    info@o9medical.com
O9medical | for Medical & consulting Logo
  • The best doctors in Turkey
  • Medical Oncology

Prof. Dr. Irfan Cicin

Prof. Dr. Irfan Cicin
Academic Title :
Prof. Dr.

Department Work location
Cancer Treatment Department Liv Topkapı

Prof. Dr. Irfan Cicin is an internal medicine and medical oncology specialist and a professor at Istinye University Faculty of Medicine. He sees patients at Liv Hospital Topkapı and Medical Park Florya Hospital in Istanbul. His clinical interests include systemic treatment of lung, breast and colorectal cancers, gynecological and genitourinary malignancies, cancer immunotherapy, molecularly guided targeted therapies and clinical oncology research.

Education and Academic Qualifications

  • Medical Degree from Cerrahpaşa Faculty of Medicine, Istanbul University (1991–1997)
  • Residency in Internal Medicine from the Faculty of Medicine, Trakya University (1997–2002)
  • Fellowship in Medical Oncology from the Faculty of Medicine, Trakya University (2005–2008)

Areas of Interest

  • Systemic, immunotherapy and targeted treatment of lung cancer in Turkey

  • Chemotherapy, endocrine therapy and targeted treatment of breast cancer in Turkey

  • Systemic and targeted treatment of colorectal cancer in Turkey

  • Medical treatment of gynecological cancers in Turkey

  • Medical treatment of genitourinary cancers in Turkey

  • Cancer immunotherapy in Turkey

  • Molecular oncology and biomarker-guided targeted cancer therapy in Turkey

  • Systemic treatment of HER2-positive breast cancer in Turkey

  • Systemic treatment of hormone receptor-positive breast cancer in Turkey

  • Biomarker-guided treatment of non-small cell lung cancer in Turkey

  • Systemic treatment of advanced and metastatic solid tumors in Turkey

  • Assessment of treatment response and management of systemic cancer therapy side effects in Turkey

  • Resident in the Department of Internal Medicine, Trakya University Faculty of Medicine (1997–2002)
  • Specialist Physician in the Department of Internal Medicine, Trakya University Faculty of Medicine (2002–2004)
  • Specialist Physician in Internal Medicine, Etimesgut Military Hospital (2004–2005)
  • Fellow in the Division of Medical Oncology, Trakya University Faculty of Medicine (2005–2008)
  • Medical Oncology Specialist, Elazığ Training and Research Hospital (2008–2010)
  • Associate Professor and Head of the Department of Medical Oncology, Trakya University Faculty of Medicine (2010–2015)
  • Professor (and Head of Department) of Medical Oncology, Trakya University Faculty of Medicine (2015–present)
  • Professor of Medical Oncology and Director of the Clinical Research Center, Istinye University, Liv Hospital Topkapı (2023–present)

  • Turkish Society of Medical Oncology (Former Board Member, Treasurer, and R&D Coordinator between 2014-2018)
  • Turkish Lung Cancer Society
  • Cancer Immunotherapy Society
  • Trakya Breast Diseases Association

  • Author of the book "Side Effect Management in Immunotherapies" (2020), a pioneering medical reference in Turkey.
  • Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised trial.
  • Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH study.
  • Is early change in systemic inflammatory markers associated with treatment response in patients who received pazopanib?
Share :